Baltimore, MDNCT07521930Now EnrollingIRB Ready

Tetraplegia/Tetraparesis Clinical Trial in Baltimore, MD

Access cutting-edge tetraplegia/tetraparesis treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Johns Hopkins University

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access tetraplegia/tetraparesis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related tetraplegia/tetraparesis treatment provided free

Apply for This Baltimore Location

Check if you qualify for this tetraplegia/tetraparesis clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Tetraplegia/Tetraparesis Study in Baltimore

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow adults affected by disabling paralysis (see Eligibility for more details) to control and receive feedback from assistive devices.

Sponsor: Johns Hopkins University

Who Can Participate

Inclusion Criteria

Complete or incomplete tetraplegia (quadriplegia), tetraparesis (quadriparesis), severe ataxia, or disabling motor impairments in both upper limbs, based on neurological exam. In addition, these motor impairments may be combined with severe motor-related speech impairment (dysarthria or anarthria), as in Locked In Syndrome (LIS) and amyotrophic lateral sclerosis (ALS), including the bulbar variant of ALS.
Clinical diagnosis must be established for the etiology of motor impairments, including brainstem stroke\*, traumatic spinal cord injury (SCI), or progressive and irreversible neuromuscular disease, including muscular dystrophy and motor neuron disease, including amyotrophic lateral sclerosis (ALS). \*Brain stem stroke is defined as an acute onset of neurological deficit with clinical features of brain stem or cerebellar dysfunction lasting more than 24 hours together with computed tomography (CT) or magnetic resonance imaging (MRI) evidence of ischemic infarction or parenchymal hemorrhage.
Candidates with traumatic spinal cord injury must have a complete or incomplete tetraplegia or tetraparesis (ASIA Impairment Scale A, B, C) with an injury level of C6 or higher.
Candidates with tetraplegia or tetraparesis from traumatic SCI and other non-progressive neurological disorders must have an upper extremity motor score (UEMS, ISNCSCI) of 7 or less in each of the upper extremities. Candidate must also have less than antigravity strength (\< 3) throughout the lower limbs.
Candidates with progressive conditions with shortened life expectancy, such as ALS, must have less than antigravity strength (\<3) throughout the upper limbs.
Persistence of motor impairments at least 12 months prior to enrollment if due to a non-progressive neurological cause such as stroke or spinal cord injury
Meeting surgical safety criteria, including surgical clearance by the participant's primary healthcare provider, study physicians, and any necessary consultants
Ability to communicate reliably, such as through speech or eye movement
Stable psychosocial support system with caregiver capable of monitoring participant throughout the study
Ability and willingness to travel to study location up to five days per week for the duration of the study
Ability to understand and comply with study session instructions
Corrected visual acuity sufficient for use of computer monitor

Exclusion Criteria

Psychiatric conditions or cognitive impairments that would interfere with obtaining informed consent or fully participating in study activities.
Individuals with active implanted devices, including devices that are incompatible with magnetic resonance imaging (MRI).
Contraindications to MRI or anticipated need for an MRI during the study period
Medical conditions contraindicating device implantation surgery (for example significant pulmonary, cardiovascular, metabolic, or renal impairments making the surgical procedure unsafe)
Chronic anti-coagulation and medical contraindication to temporary suspension for surgery
Medical conditions contraindicating chronic device implantation (e.g. osteomyelitis, chronic infection, poorly controlled diabetes, cancer, severe autoimmune disorder, epilepsy, poor wound healing)
Participants with dental caries and a significant risk of dental or periodontal infection
Chronic oral or intravenous use of steroids or immunosuppressive therapy
Active cancer within the past year or ongoing chemotherapy
Uncontrolled autonomic dysreflexia within the past 3 months
Hydrocephalus with or without an implanted ventricular shunt
Other chronic, unstable medical conditions that could interfere with subject participation.
Persistent suicidal ideation within the past 12 months.
History of substance use disorder within the past year
Pregnancy (confirmation through blood test)
Nursing an infant, planning to become pregnant, or not using adequate birth control

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT07521930) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Tetraplegia/Tetraparesis Treatment Options in Baltimore, MD

If you're searching for tetraplegia/tetraparesis treatment options in Baltimore, MD, this clinical trial (NCT07521930) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tetraplegia/tetraparesis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all tetraplegia/tetraparesis clinical trials near you to find additional studies recruiting in your area.

More Spinal Cord Injury Trials in Baltimore, MD

See all spinal cord injury clinical trials recruiting in Baltimore — not just this study.

Browse Spinal Cord Injury Trials in Baltimore →

Browse More Trials by Condition

Spinal Cord Injury TrialsEssential Tremor TrialsRheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD